A recent study conducted by researchers at Brown University and
Lifespan Health System have focused on observing the effects of a concussion on
the brain and the inflammatory process that is triggered afterwards. This
approach allowed them to look at proteins that are produced in response to
injury and that are also found in the circulation. As a
result, researchers have been able to identify a panel of four
proteins in the blood that can accurately reflect the trauma of the brain
injury and more specifically, correlate it to a concussion. In fact,
researchers also found that measuring these proteins can even help to
distinguish concussions from other injuries such as bone breaks.

There have been other interesting biomarkers investigated for this purpose in the past but due their low levels and the complexity of their testing, their use was limited for implementation in routine testing. Thus the recent discovery of the four proteins: copeptin, galectin 3 (LGALS3), matrix metalloproteinase 9 (MMP-9) and occludin is an exciting breakthrough because scientists were able to easily measure their concentrations with standard immunoassays. It is the first testing that shows amazing promise for objectively and effectively diagnosing traumatic brain injury/concussion. This study demonstrated that these four proteins reveal a dramatic change in concentration in the bloodstream shortly after concussion. Two of these proteins, galectin 3 and occludin provided insight to distinguish patients who suffered concussion from those who suffered from orthopedic injuries.Read More


2 Reasons these analytes should be Explored further:

1.They could provide quick and easy detection/diagnosis of  traumatic brain injury.

2.They could be a potential target for therapy for patients with brain injuries.


Related Kits:

MMP-9
ELISA

 

 

 

A recent animal study at Henry Ford Hospital focused on researching the potential of the drug, sildenafil’s (a.k.a. Viagra) ability to treat nerve damage in men with long-term diabetes.  Scientists’ specifically targeted diabetic peripheral neuropathy which is the most common complication of diabetes.  A cohort of mice were carefully selected in order to obtain a large sampling of mice that aligned with the target clinical population in terms of age and diabetic type/status.  

The study was successful, proving that sildenafil is useful in remarkably improving sensory function just weeks after administering the drug to the mice in the test group as compared to the mice in the saline control group. Read More

 

3 Reasons Sildenafil/Viagra Treatment Should be Studied Further:

1. Results of this study have revealed positive effects on neurological function:

Diabetic neuropathy is an incredibly insidious, thus quickly damaging nerves in various parts of the body and often doing so without being discovered until it is too late leading to amputation or even death. This drug may have potential to reverse and/or prevent this condition from occurring.

2. Possibility of treatment without side effects:

Other drugs that have been used to treat pain from diabetic neuropathy have harmful/undesirable side effects.

3. Other potential applications:

This study is just the beginning. Additional studies may reveal that sildenafil/viagra may be a potential target for other areas of research and medical diseases/conditions.

 

Read More

image from nbcnews.com

Related Kits:

Insulin ELISA Assay Kit

Insulin Ultrasensitive ELISA Assay Kit

Endocrine Assay Kits

 

Eagle Buzz

Learn, Answer, & Win!

Answer the question below for a chance to win a:

$10 Starbucks gift card or an EagleBio tote bag

 

           +

 

EagleBio discount of 20% (up to $200)

 

Which of our assays was recently featured in a webinar hosted by Eagle Biosciences and NBCL? And what is the title of the scientific poster presenting these assays at AACC 2014? (Hints: It is more than one assay, they are in our Steroid Assay Kits product line, and they were featured in our Q4 2014, Eagle i-View)

 

Email us to Win! 

 

 

*Offer is good while supplies last with correct answers to questions.

 




Utilizing urine as a source to generate electricity is quite odd and definitely a little off-putting and why in the world would you want to do that?!

A recent study at the University of the West of England (UWE Bristol) has proved that it is in fact a creative idea. These researchers focused first on designing ways to use urine to power mobile phones. They were able to demonstrate that electricity generated by microbial fuel cell stacks (MFC) could create the power that they needed by employing live microbes which feed on urine (fuel) for their own growth and maintenance. The MFC is an efficient system which extracts a portion of the biochemical energy used for microbial growth,and thereby converts that directly into electricity or as the scientists refer to it as urine-tricity or pee power.  Learn More

The MFC Techonology is:

1. Green: 

Utilizing a waste product that is in plentiful supply is always a wise choice because it provides an efficient and cost effective means without the use of fossil fuels.


2. Versatile:

This technology could be used anywhere and potentially for numerous other applications. In fact, they are looking to try this in refugee camps to light up toilets to provide safety to women from being assaulted when using the bathroom after dark. 





image above from www.sciencedaily.com


Eagle iView Q1 2015 Edition is Out!


Eagle Biosciences is pleased to announce that the Eagle iView Newsletter Q1 2015 was just released! Here is what you will find:


Fascinating Research

Exciting Announcements

Chance to Win Great Prizes


Don’t miss out! View the latest information, products, and promotions from Eagle Biosciences:

Click here to view the Eagle iView

Interesting Study Reveals Possible Link Between Vitamin D and Autism


A recent study at the Children’s Hospital Oakland Research Institute (CHORI) investigated the effect that Vitamin D may have on social behavior associated with autism.  This research demonstrated that three hormones in the brain that affect social behavior: serotonin, oxytocin, and vasopressin are activated by the vitamin D hormone. In fact, researchers discovered that vitamin D has several vital roles and may be necessary for the production of serotonin in the brain. The results of this study further revealed that Vitamin D, tryptophan, and omega 3 fatty acids supplementation could potentially lift serotonin levels in the brain enough to relieve some of the symptoms without side effects.  Learn More

image above from: www.sciencedaily.com

Related Kits: 

Vitamin D ELISA Assay Kit

50 Examples: Saying "Thank You" To Your Facebook Fans


Eagle Biosciences is pleased to announce reaching a new social media milestone of reaching 1,000 likes on our Facebook page! We would like to sincerely thank all of our followers, new and old, for helping us get there. We truly appreciate your continued engagement and support. Eagle Biosciences promises to continue to bring you interesting posts, new research, and more!



Find us on:

Facebook: www.facebook.com/Eaglebioscience

Twitter:      www.twitter.com/Eaglebioscience




image above from www.viralblog.com

New Hormone Discovery:  Could it Lead to Ground Breaking Therapy for Type 2 Diabetes?


 

A recent study revealed
that researchers and Scientists at University of Southern
California Leonard Davis School of Gerontology have made an amazing
discovery of a new hormone, Mitochondrial-Derived
Peptide( a.k.a. MOTS-c).
This hormone has been found to
mimic the effects of exercise in that it has proven to combat weight gain
caused by a high fat diet and to balance metabolism. The mechanism of
action for hormone involves triggering a physiological responsein
muscle tissue which is the prime location of insulin sensitivity restoration
thereby normalizing or counteracting diet-induced
and age-dependent insulin resistance.

The effects of MOTS-c has been
tested in mice by injecting mice that had been fed a high fat diet with this
hormone and researchers concluded that this study was very successful. In
fact, the results revealed that not only had this hormone suppressed the
effects of a high fat diet such as growing obese and developing insulin
resistance, it also reversed age-dependent insulin resistance.

This study certainly brings
hope for age-dependent diseases such as diabetes but potentially a whole host
of other disease/conditions as well. The discovery of MOTS-c is a major
advance in the identification and search for a new target for therapy and
treatments.
Learn More

 

 

 

 

Related Kits:

Insulin ELISA Assay Kit

Insulin Ultrasensitive ELISA Assay Kit

IAA (Insulin Autoantibodies) ELISA Assay Kit

Endocrine Assay Kits

 

EagleBio’s March Promotions

 

Check Out our Monthly Promotions! 

30% Discount on Select Cardiac Biomarker Assays


BNP Fragment ELISA

NT-proCNP ELISA

NT-proANP ELISA

Endostatin ELISA

Big Endothelin-1 ELISA

Endothelin (1-21) ELISA

 

This promotion is good through the end of March just use the code below when ordering. 

PROMOTIONAL CODE: CARD0230 

 

 

Related News:

EagleBio Spotlight: Endothelin

EagleBio Spotlight: Natriuretic Peptides

EagleBio Spotlight: ANP

EagleBio Spotlight: CNP

EagleBio Spotlight: BNP

Interesting Study Highlighting Eagle Biosciences’ BNP Fragment ELISA Assay Kit 

EagleBio Spotlight: Endostatin

Eagle Biosciences Introduces Endothelin 1-21 and Big Endothelin-1 ELISA Kit

 

 

Related Resources Citing EagleBio Kits:

Stanek, B. et al. “Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction” Journal of American Cardiology 2001; 38: 436-442.

 

Related kits:

Cardiovascular Assay Kits

 

EagleBio Spotlight: Endothelin

 

What
are Endothelins?

Endothelins are a family of peptides, which comprises endothelin-1
(ET-1), endothelin-2 (ET-2) and endothelin-3 (ET-3), each containing 21
amino-acids.Endothelins were
discovered in 1988 when isolated from porcine aortic endothelial cells. They are long-acting vasoconstrictor substances
that play a strong, important role in blood pressure regulation and sodium and
fluid homeostasis. Other functions of
the ET system involve renal microcirculation regulation and they have been
found to contribute to the pathogenesis of renal injury.

The biological role of ET extends
beyond regulating vascular tone also in its growth regulatory properties. The
peptide interacts in an autocrine/paracrine manner with specific ET receptors
found on numerous cells, including smooth muscle cells, myocytes, and
fibroblasts. The half-life of ET in the
plasma is less than one minute, whereas clearance of Big ET is much slower,
therefore Big ET more accurately reflects the relative physiological effect.
Endothelin has been identified in a variety of tissues, including lung, kidney,
brain, pituitary and peripheral endocrine tissues and placenta.

Summary of Biological Functions:

Regulation of:

  • Blood pressure
  • Vascular tone
  • Sodium and fluid homeostasis
  • Renal microcirculation
  • Autocrine and paracrine functions

Why Measure Endothelins?

Since the principal actions of
endothelin surround increasing blood pressure and vascular tone, endothelin
antagonists may serve to play important parts in offsetting the negative impact
endothelin has in invivo. Past studies have focused on observing the mediation
of the pathogenesis of hypertension and its complications. More specifically,
some studies have demonstrated that ET-1 plays an significant role in the
progression of coronary artery disease(CAD) and subsequent plaque rupture and
ACS onset. In addition, findings from other studies have proven that Big ET-1
and ET-1 are strong independent predictors of survival in patients with severe
CHF. Based on this research, it is
believed that anti-endothelin therapy can help to improve symtoms and
potentially be used as treatment in such conditions as vascular remodelling,
left ventricular hypertrophy, hypertensive kidney damage and atherosclerosis. However, due to the complex nature of the
endothelin system, further research may be necessary to further define these
biological intricacies for the development of therapeutic agents. Robust, sensitive, and specific immunoassays
could be valuable tools to assist researchers in these investigations.

Biosynthesis
of Endothelins

The synthetic Endothelin pathway begins with a 212
amino acid peptide, called preproendothelin-1 which is then converted to
proendothelin-1 following a cleavage and removal of a short secretory
sequence. Furin (A protein that in
humans is encoded by the FURIN gene, its main function is to cleave proteins
just downstream of a basic amino acid target sequence) then prompts the
cleavage of proendothelin-1 to create biologically-inactive, 38 amino-acid
precursor called Big Endothelin. Big Endothelin-1
is then cleaved to yield endothelin-1 prompted by the action of several
endothelin-converting enzymes (ECE). Big Endothelin-1 can also be hydrolyzed by
chymase (serine proteases that have chymotrypsin-like cleavage properties) to
generate endothelin (1-21) in vitro.

What is Big Endothelin 1?

Big Endothelin-1 is a biologically-inactive
peptide and 38 amino-acid precursor with a plasma half-life of 30 minutes. Since
Plasma ET-1 has a much shorter half-life (about 1.5 min) and it has proven to
be problematic to measure circulating concentrations, Big Endothelin-1 has
become an excellent tool for measuring and monitoring the endothelin system
activation due to its inherent 
stability.

What is Endothelin 1-21?

Endothelin 1-21 is a potent vasoconstrictor and is created by the cleavage of Big Endothelin by a membrane-bound metalloproteinase, the Endothelin Converting Enzyme (ECE). This process yields active ET 1-21 and also the biological inactive C-terminal fragment (22-38) as described above.

Research and Indications:

The intrinsic biological function of Big ET-1 is
still under investigation as many aspects of its role are still unknown. However, recent studies suggest that this
analyte may work in opposition to ET-1 utilizing ET receptors and thereby
stimulating diueresis and natriuresis.
In fact, a very large study, Masson et al 2006 revealed
that ET stimulates the release of natriuretic peptides: ET participates in the
mechanical stretch-induced release of BNP by atrial myocytes. This research involved monitoring and
measuring various analytes with Big ET-1 serving as the main focus of study for
the cohort of 2,300 heart failure patients. This research also clearly
demonstrated that plasma concentrations of BNP show a strong and independent
association with Big ET using our Big Endothelin-1 ELISA Assay Kit.

In past studies, it has been
discovered that Big-Endothelin levels raise significantly in patients with
various types of tumors
and increased concentrations of this analyte have been
corrleated to worse outcomes. Teng et al 2006 investigated the levels of Big-Endothelin-1 in plasma of
gastric carinoma patients before and after radical gastroectomy utilizing our Big Endothelin-1 ELISA Assay Kit. It was evident from the results of this study
that there is a corrleation between the increase in Big ET-1 plasma levels and
the progression of tumors. Therefore, not
only could this analyte serve as a tumor marker for gastric cancer but it could
also serve as a powerful tool in monitoring recurrent disease.

Another
interesting study Arun et. al 2004 that utilized our Big Endothelin-1 ELISA Assay Kit, evaluated
the expression of Big ET-1 and ET-1 in non-small cell lung cancer (NSCLC). This was the first study to investigate this
analyte in this particular area of cancer research and more specifically, NSCLC. Since lung cancer is one of the most common
causes of cancer-related death in the Western world, there has been a great
need to further explore and understand the molecular biology of this
diseases. It discovered from the
results of this study that ET-1 and Big ET-1 are synthesized by NSCLC tumor in
vitro as well as in vivo and elevated levels have been associated with poor
outcomes. This evidenece has lead
invesigators to believe that ET-1 and Big ET-1 could serve as strong biomarkers
of this disease and as potential novel targets for treatment of NSCLC.

References:

  1. Agapitov, Alexei et al. “Role of Endothelin in Cardiovascular Disease.” JRAAS, 2002; 3:1-15.
  2. Arun, C. et al.  Endothelin-1 is a Novel Prognostic Factor in Non-Small Cell Lung Cancer.” Journal of Biological Markers 2004; 19 (4):262-267.
  3. Beneden, Van et al. “Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure: a 7-year follow-up study.”J Card Fail. 2004 Dec; 10(6):490-5.
  4. Burg MM et al. “Depression Predicts Elevated Endothelin-1 in Patients With Coronary Artery Disease.” Psychosom Med 2011; 73: 2-6.
  5. Harrison-Benard, Lisa et al. “Enhanced Vascular Chymase-Dependent Conversion of Endothelin in the Diabetic Kidney.” The Oschner Journal 2013 13:1, 49-55.
  6. Jiao, Wenjie et al. “Elevation of circulating big endothelin-1: an independent prognostic factor for tumor recurrence and survival in patients with esophageal squamous cell carcinoma.” BMA Cancer 2008, 8:334.
  7. Masson et al. “The Prognostic Value of Big Endothelin-1 in More than 2,300 Patients with Heart Failure Enrolled in the Valsartan Heart Failure Trial (Val-HeFT).”Journal of Cardiac Failure 2006; 12: 375-380.
  8. Teng et al. “Pre- and Post-operative Plasma Big-Endothelin-1 Levels in Patients with Gastric Carcinoma Undergoing Radical Gastrectomy.” Anticancer Research 2006; 26: 2503-2508.
  9. Verghese, Mathew et al. “Clinical Implications of a Sandwich Enzyme Immunoassay for Big Endothelin-1.” Clinical Chemistry 1997; 43: 9-10. 

 

Related Kits:

Endothelin (1-21) ELISA Assay Kit

Big Endothelin-1 ELISA Assay Kit

Cardiovascular Assay Kits

 

 

Related News:

Eagle Biosciences Introduces Endothelin 1-21 and Big Endothelin-1 ELISA Kit